A paradigm shift in drug delivery systems

TissueGen's proprietary technology makes possible extended release formulations for drugs ranging from small molecules to temperature-sensitive biologics. Our patent-protected technology is particularly well suited to creating a new class of drug-eluting devices designed to orchestrate the body's own healing processes to significantly improve clinical outcomes after trauma or surgery.

ABOUT

biologics. Our patent-protected technology is particularly well suited to creating a new class
release formulations for drugs ranging from small molecules to temperature-sensitive
TissueGen's proprietary technology makes possible extended
of drug-eluting devices designed to orchestrate the body's own healing processes
 to significantly improve clinical outcomes after trauma or surgery. 

- Dr. Kevin Nelson, Founder and CSO

APPLICATIONS

A

D

V

A

N

C

E

D

R

E

G

E

N

E

R

O

I

T

A

N

E

N

G

I

N

E

E

G

N

I

R

 
 

TissueGen, Inc.
2110 Research Row, Suite 330
Dallas, Texas 75235
+ 1.214.351.1922
info@tissuegen.com

  • Facebook
  • Twitter
  • Instagram

Site produced by Lovage Inc.